343 related articles for article (PubMed ID: 1734177)
1. Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.
Rubin DL; Muller HH; Young SW
Magn Reson Med; 1992 Jan; 23(1):154-65. PubMed ID: 1734177
[TBL] [Abstract][Full Text] [Related]
2. Methods for the systematic investigation of gastrointestinal contrast media for MRI: evaluation of intestinal distribution by radiographic monitoring.
Rubin DL; Muller HH; Young SW
Magn Reson Imaging; 1991; 9(3):285-93. PubMed ID: 1908931
[TBL] [Abstract][Full Text] [Related]
3. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Low RN; Francis IR
AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.
Kettritz U; Warshauer DM; Brown ED; Schlund JF; Eisenberg LB; Semelka RC
Eur Radiol; 1996; 6(1):14-8. PubMed ID: 8797944
[TBL] [Abstract][Full Text] [Related]
5. Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.
Marchal G; Zhang X; Ni Y; Van Hecke P; Yu J; Baert AL
Magn Reson Imaging; 1993; 11(5):665-74. PubMed ID: 8345781
[TBL] [Abstract][Full Text] [Related]
6. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
Shuter B; Tofts PS; Wang SC; Pope JM
Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190
[TBL] [Abstract][Full Text] [Related]
7. A novel manganese chelated macromolecular MRI contrast agent based on O-carboxymethyl chitosan derivatives.
Wang X; Xu L; Ren Z; Fan M; Zhang J; Qi H; Xu M
Colloids Surf B Biointerfaces; 2019 Nov; 183():110452. PubMed ID: 31473409
[TBL] [Abstract][Full Text] [Related]
8. [Oral contrast media for magnetic resonance tomography of the abdomen. 1. Comparative animal studies of positive and negative contrast media].
Laniado M; Kaminsky S; Semmler W; Weinmann HJ; Zurth C; Claussen C
Rofo; 1987 Sep; 147(3):325-32. PubMed ID: 2445010
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
[TBL] [Abstract][Full Text] [Related]
10. MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction.
Leander P; Golman K; Klaveness J; Holtz E; Olsson M; Leunbach I
Invest Radiol; 1990 Oct; 25(10):1130-4. PubMed ID: 2127772
[TBL] [Abstract][Full Text] [Related]
11. Preliminary evaluation of iron phytate (inositol hexaphosphate) as a gastrointestinal MR contrast agent.
Unger EC; Fritz TA; Palestrant D; Meakem TJ; Granstrom P; Gatenby RA
J Magn Reson Imaging; 1993; 3(1):119-24. PubMed ID: 8428077
[TBL] [Abstract][Full Text] [Related]
12. Equilibrium signal intensity mapping, an MRI method for fast mapping of longitudinal relaxation rates and for image enhancement.
Surányi P; Kiss P; Ruzsics B; Brott BC; Simor T; Elgavish GA
Magn Reson Imaging; 2007 Jun; 25(5):641-51. PubMed ID: 17540275
[TBL] [Abstract][Full Text] [Related]
13. Paramagnetic oil emulsions as oral magnetic resonance imaging contrast agents.
Li KC; Ang PG; Tart RP; Storm BL; Rolfes R; Ho-Tai PC
Magn Reson Imaging; 1990; 8(5):589-98. PubMed ID: 2082129
[TBL] [Abstract][Full Text] [Related]
14. MR imaging of the gastrointestinal tract: value of Gd-DTPA.
Laniado M; Kornmesser W; Hamm B; Clauss W; Weinmann HJ; Felix R
AJR Am J Roentgenol; 1988 Apr; 150(4):817-21. PubMed ID: 3126628
[TBL] [Abstract][Full Text] [Related]
15. Liquid oral magnetic particles as a gastrointestinal contrast agent for MR imaging: efficacy in vivo.
Rubin DL; Muller HH; Sidhu MK; Young SW; Hunke WA; Gorman WG
J Magn Reson Imaging; 1993; 3(1):113-8. PubMed ID: 8428076
[TBL] [Abstract][Full Text] [Related]
16. Ni-DTPA doped agarose gel--a phantom material for Gd-DTPA enhancement measurements.
Tofts PS; Shuter B; Pope JM
Magn Reson Imaging; 1993; 11(1):125-33. PubMed ID: 8423715
[TBL] [Abstract][Full Text] [Related]
17. High resolution NMR imaging: Gd-DTPA labeled enzyme as a probe for permeability studies in polyacrylamide gels.
Spanoghe M; Lanens D; Gorrebeeck C; Dommisse R; Lemière G; Van der Linden A; Van de Vyver F
Magn Reson Imaging; 1991; 9(4):583-7. PubMed ID: 1779730
[TBL] [Abstract][Full Text] [Related]
18. MR imaging of pancreatic lesions. Comparison of manganese-DPDP and gadolinium chelate.
Diehl SJ; Lehmann KJ; Gaa J; McGill S; Hoffmann V; Georgi M
Invest Radiol; 1999 Sep; 34(9):589-95. PubMed ID: 10485075
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Evaluation of Manganese(II)-Based Ethylenediaminetetraacetic Acid-Ethoxybenzyl Conjugate as a Highly Stable Hepatobiliary Magnetic Resonance Imaging Contrast Agent.
Islam MK; Kim S; Kim HK; Kim YH; Lee YM; Choi G; Baek AR; Sung BK; Kim M; Cho AE; Kang H; Lee GH; Choi SH; Lee T; Park JA; Chang Y
Bioconjug Chem; 2018 Nov; 29(11):3614-3625. PubMed ID: 30383368
[TBL] [Abstract][Full Text] [Related]
20. Enteric MRI contrast agents: comparative study of five potential agents in humans.
Tart RP; Li KC; Storm BL; Rolfes RJ; Ang PG
Magn Reson Imaging; 1991; 9(4):559-68. PubMed ID: 1779727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
